Recent data have shown that the inadequate vitamin D status plays a role in the manifestation of the haematologic tumors and serum vitamin D level has a prognostic role also as it determines the tumor mortality. But data have not proved a causal relationship between the inadequate vitamin D status and the unfavourable outcomes so far. It is also still unknown, whether the normalization of vitamin D status in patient with vitamin D inadequacy is able to improve the prognosis and survival. In this study the investigators examine the role of the adequate vitamin D substitution in the improvement of the outcomes of haematologic disorders.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
31
180.000 IU monthly
Placebo comparator, 9 ml monthly
Semmelweis University - 1st Departement of Internal Medicine
Budapest, Hungary
Overall survival
Time frame: up to 5 years
Time to treatment needed
Time frame: up to 5 years
Blood lymphocyte count
Time frame: monthly, up to 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.